Biofl 250 Powder (Saccharomyces boulardii)
Saccharomyces Boulardii 282.5mg
OTC medication
Geonil Pharmaceutical Co., Ltd.
MFDS item code 201006974 · Notified 2010.11.23 · Insurance code 646802471
Improvement of dysbiosis (restoration of flora, constipation, etc.)
This medicine is used to improve various symptoms caused by dysbiosis in the intestinal flora due to the administration of antibiotics or chemotherapeutics. It particularly helps with the restoration of the flora and regulates constipation and diarrhea, alleviating discomfort caused by abdominal bloating or abnormal fermentation in the intestine. Therefore, it helps restore gut health and improve the overall digestive symptoms by enhancing the intestinal environment.
Adults and children over 12 years: 1 to 2 packets orally 2 times a day
Ages 3 to 12 years: 1 packet orally 3 times a day Under age 3: 1 packet orally 2 times a day
This medication should not be administered to patients using central venous catheters, critically ill patients, and those with weakened immune systems. This medication contains lactose, so it should not be used by patients with a genetic problem that prevents the breakdown of lactose. Additionally, this medication contains fructose, and it should not be administered to patients who cannot digest fructose. Patients undergoing treatment should consult a physician carefully before using this medication. If allergic symptoms such as itching, hives, skin rash, and angioedema occur after taking this medication, the medication should be discontinued immediately and a specialist should be consulted. Attention is also needed as serious immune reactions such as anaphylaxis may occur. Gastrointestinal problems may present as abdominal bloating or constipation; if these symptoms persist, a specialist should be consulted. This medication must be taken strictly according to the prescribed dosage and frequency, especially in children, where it should be administered under the supervision of a guardian. If symptoms do not improve after taking the medication for more than one month, it is important to discontinue use and consult a doctor or pharmacist. The fructose component in this medication may affect dental health with long-term use, so caution is advised. For infants under 3 months, it is essential to consult a specialist before administering this medication. It is preferable not to open this medication around patients using central venous catheters or those with weakened immune systems. While taking this medication, serious infections such as fungemia or sepsis may rarely occur, so if symptoms appear, consult medical personnel immediately. Finally, this medication should be stored out of reach of children, away from direct sunlight and in a cool, dry place in its original packaging. Additionally, to maintain quality, it should not be transferred to another container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it must be stored in a tightly sealed container. It is recommended to store it at room temperature—not too hot or too cold, ideally between 1 and 30 degrees Celsius. This way, the effectiveness of the medication can be well maintained.
Pale yellow powder
200 packets/case
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Saccharomyces Boulardii 282.5mg
OTC medication
Geonil Pharmaceutical Co., Ltd.

Saccharomyces Boulardii 282.5mg
Hard capsule · OTC medication
Teragen Etex Co., Ltd.

Saccharomyces Boulardii 282.5mg
Hard capsule · OTC medication
Gunil Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.